Compound Detail
CHEMBL74656
REL-CISAPRIDE Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL74656 |
| Name | REL-CISAPRIDE |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DCSUBABJRXZOMT-RBBKRZOGSA-N |
7
Targets
29
Activities
3
Assay Types
6
PK Parameters
20
Publications
0
Known Names
Molecular Properties
465.9
MW (Da)
3.36
ALogP
6
HBA
2
HBD
86.0
PSA (Ų)
0.44
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 23 meas. best 8.7
EC50 3 meas. best 7.7
Ki 3 meas. best 7.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 8.7 | 7.1894 | 2.0 | 18 |
| 5-hydroxytryptamine receptor 4 CHEMBL1875 | EC50 | 7.7 | 7.4 | 19.9 | 2 |
| 5-hydroxytryptamine receptor 4 CHEMBL5017 | Ki | 7.7 | 7.7 | 20.0 | 1 |
| 5-hydroxytryptamine receptor 4 CHEMBL1875 | Ki | 7.0 | 7.0 | 100.0 | 2 |
| 5-hydroxytryptamine receptor 4 CHEMBL4317 | EC50 | 6.99 | 6.99 | 102.3 | 1 |
| 5-hydroxytryptamine receptor 4 CHEMBL1875 | IC50 | 6.32 | 6.32 | 483.0 | 1 |
| A2780 CHEMBL614004 | IC50 | 5.28 | 5.28 | 5267.0 | 1 |
| HUVEC CHEMBL613979 | IC50 | 4.86 | 4.86 | 13900.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.36 | 4.335 | 43810.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 142.0 | ng.hr.mL-1 | Rattus norvegicus |
| Cmax | 223.2 | nM | Rattus norvegicus |
| T1/2 | 0.7833 | hr | Rattus norvegicus |
| T1/2 | 47.0 | hr | Rattus norvegicus |
| T1/2 | 1.48 | hr | Rattus norvegicus |
| Tmax | 0.25 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 26761776 | 10.1016/j.ejmech.2015.12.006 | Rattus norvegicus | 6 |
| 35737669 | 10.1021/acs.jmedchem.2c00608 | Unchecked | 3 |
| 22959244 | 10.1016/j.bmcl.2012.08.051 | 5-hydroxytryptamine receptor 4 | 3 |
| 22683222 | 10.1016/j.bmcl.2012.05.034 | 5-hydroxytryptamine receptor 4 | 3 |
| 30108781 | 10.1039/C6MD00458J | 5-hydroxytryptamine receptor 4 | 3 |
| 26761776 | 10.1016/j.ejmech.2015.12.006 | 5-hydroxytryptamine receptor 4 | 2 |
| 26761776 | 10.1016/j.ejmech.2015.12.006 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 37651874 | 10.1016/j.ejmech.2023.115742 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 33395621 | 10.1016/j.ejmech.2020.113096 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 33246105 | 10.1016/j.bmcl.2020.127710 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 31099559 | 10.1021/acs.jmedchem.9b00518 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 31158742 | 10.1016/j.ejmech.2019.05.051 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 30698430 | 10.1021/acs.jmedchem.8b01750 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| - | 10.1101/2020.04.03.023846 | SARS-CoV-2 | 1 |
| 22959244 | 10.1016/j.bmcl.2012.08.051 | Unchecked | 1 |
| 22959244 | 10.1016/j.bmcl.2012.08.051 | Rattus norvegicus | 1 |
| 22959244 | 10.1016/j.bmcl.2012.08.051 | Liver microsomes | 1 |
| 22959244 | 10.1016/j.bmcl.2012.08.051 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 22683222 | 10.1016/j.bmcl.2012.05.034 | Liver microsomes | 1 |
| 22683222 | 10.1016/j.bmcl.2012.05.034 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine